ADC Therapeutics SA (ADCT) vs MacroGenics, Inc. (MGNX)
- ADC Therapeutics SA ADCT 1.41 −5.37%
- MacroGenics, Inc. MGNX 3.25 −3.56%
ADC Therapeutics SA and MacroGenics, Inc. are both Biotechnology companies. MacroGenics, Inc. is the larger, with a market value of $214.7M against $190.2M — 1.1× the size. MacroGenics, Inc. grew revenue faster over the last twelve months: 21.9% against 3.03%. MacroGenics, Inc. has the higher net margin (−7.97% vs −121.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, MacroGenics, Inc. leads on 9 and ADC Therapeutics SA on 7.
Valuation
Profitability
| Metric | ADCT | MGNX | Biotechnology median |
|---|---|---|---|
| Gross margin | 88.86% | 78.07% | 65.16% |
| Operating margin | (125.08%) | (18.73%) | 0.00% |
| Net margin | (121.77%) | (7.97%) | 0.00% |
| Free cash flow margin | (127.72%) | (35.80%) | 0.00% |
| Return on equity | 45.35% | (32.61%) | (56.36%) |
| Return on assets | (32.25%) | (4.94%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack